As shown in Table 1, methylation of RASSF10 was significantly associated with tumor size (P < 0.05) and tumor stage (P < 0.05), but no association was found between RASSF10 methylation and age, gender, HBV infection, cirrhosis, lymph node metastasis and cell differentiation. Here, RASSF10 is linked to neoplasm.